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Abstract
Background: Previous studies have pointed to a relation between 
high serum levels of ferritin and insulin resistance. 
Objective: To analyze the association between the serum concentra-
tions of ferritin and resistance to insulin, and metabolism of glucose, 
in nondiabetic persons. 
Method: A transversal study was undertaken with 151 nondiabetic 
persons in São Luís, Brazil, in 2013. The following biochemical variables 
were analyzed: glycated hemoglobin, fasting glycemia, fasting insulin, 
total cholesterol, triglycerides, HDL-cholesterol, LDL-cholesterol, serum 
ferritin and high-sensitivity C reactive proteins (hs-CRP).
Results: Among the participants with high levels of ferritin, approxi-
mately 20% and 40%, respectively, also had raised LDL-C (p=0.040) 
and hs-CRP (p=0.021). Prediabetes (p=0.016) and insulin resistance 
(p=0.026) had a statistically significant association with high levels of 
ferritin. The participants with raised ferritin also had double the pro-
bability of having raised hs-CRP (odds ratio = 2.29/p=0.036).
Conclusion: There was a statistically significant association between 
prediabetes and insulin resistance and raised levels of ferritin. 
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Authors have observed that carriers of hemochromatosis have an 
accumulation of iron in the hepatocytes and altered insulin metabo-
lism [1]. The mechanism which links overload of iron to the develop-
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ment of diabetes is not yet completely established. 
However, publications have presented evidence of 
the influence of iron status on the metabolism of 
glucose, even in the absence of significant over-
load of iron [2-4]. 
In the general population, iron stocks have been 
associated positively with a greater area of subcu-
taneous visceral fat, with the development of into-
lerance to glucose, with type 2 diabetes (DM2) and 
with gestational diabetes. Previous studies have also 
pointed to a relation between high serum levels of 
ferritin and glycated hemoglobin in persons with 
metabolic syndrome (MetS), termed prediabetes by 
some authors [5-9].
As a result, it is possible to assert that the rise in 
the concentrations of serum ferritin in non-patholo-
gical conditions reflects a subclinical iron overload. 
On the other hand, it has been observed that fre-
quent blood donation and specific diets result si-
multaneously in the reduction of the iron reserves, 
improvement of insulin sensitivity, and protection 
against developing DM2 [10-11]. 
It is important to highlight that iron is an essen-
tial mineral for human health, found in foods such 
as eggs, spinach and red meats, and that it must 
always be consumed. As a result of this, researchers 
emphasize that further studies must be undertaken 
on this issue prior to promoting an antidiabetic diet 
based on the control of ingestion of iron in nondia-
betic persons. In the case of those with prediabe-
tes, it is recommended that they should reduce the 
quantity of iron in their diet, under the guidance of 
a health professional [11]. 
To the best of our knowledge, there are no re-
cords of scientific publications on this issue with 
diabetic or healthy patients in Brazil. On the other 
hand, Brazilian health authorities recommend the 
undertaking of studies, debates and interventions 
with the aim of preventing new cases of diabetes. 
Approximately 12 million people in Brazil have this 
disease, which increases their chances of death by 
6.4 times [12]. 
As a result, this study aimed to ascertain the as-
sociation between the serum concentrations of fe-
rritin and insulin resistance (IR) and metabolism of 
glucose in nondiabetic persons. 
Method
This is a quantitative study of the transversal and 
analytic type, undertaken with persons of São Luís, 
Maranhão, Brazil, in 2013. 
The present study was approved by the Research 
Ethics Committee of the Teaching Hospital of the 
Federal University of Maranhão.  All the patients 
received explanations regarding the objectives and 
methodology of the study prior to signing the terms 
of free and informed consent. 
The study population was made up of patients 
of a public hospital in the above-mentioned place 
and period. The study participants were nondia-
betic persons aged ≥ 18 years old, of both sexes, 
and for whom medical staff had requested the 
following examinations: Glycated Hemoglobin 
(HBA1c), Fasting Blood Glucose (FBG), Insulin (FI), 
total Cholesterol (T-Chol), Triglycerides, HDL cho-
lesterol (HDL-C), LDL cholesterol (LDL-C), Serum 
ferritin and high-sensitivity C-reactive protein 
(hs-CRP). The following were excluded from the 
study: persons with iron deficiency or who were 
using medications with iron present in their com-
position; persons with cardiac diseases (declared 
in the patient’s medical records) and pregnant 
women. 
In the comparative analysis of the above-mentio-
ned metabolic and inflammatory parameters, the 
recommendations of the Brazilian Diabetes Society 
and of the Brazilian Guidelines on Dyslipidemias and 
Guidelines on Prevention of Atherosclerosis of the 
Brazilian Society of Cardiology for healthy persons 
were used as reference values [12-13].
Another variable analyzed was the homeostatic 
model assessment insulin resistance (HOMA-IR) le-
vel. Values ≤ 3.4 were considered normal[14].
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Bartlett’s test was used for evaluating the ho-
mogeneity of the variables. In the inferential item, 
tests of association were undertaken between 
the categorical variables, using the Chi-squared 
test or Fisher’s Exact test when applicable. In the 
comparison of the means, the Student t-test and 
Mann-Whitney test were used according to the 
homogeneity of the variables. In order to evaluate 
the predictive capacity, an association was made 
between the levels of ferritin and each one of the 
glycemic markers studied, through calculations of 
the weighted odds ratio using the Mantel-Haenszel 
Chi-squared test. A confidence interval of 95% was 
adopted in all the analyses. 
Results
The sample was made up of 151 eligible persons, 56 
men (37%) and 95 women (63%) based on a po-
pulation of approximately 300 nondiabetic subjects. 
The group’s mean age was 54.9 (SD±14.0) years 
old. In a substantial proportion of the participants, 
the parameters referent to the normal stratification 
were predominant in the parameters referent to the 
glycidic profile: fasting blood glucose (86%), HOMA 
level (76.2%) and insulin (96.7%). Only in the eva-
luation of the Hb A1c was predominance of those 
classified as prediabetics observed (60.3%). 
Similarly, in the evaluation of the lipid profile, was 
observed of subjects with normal classification in 
the items of HDL-C (69.5%) and triglycerides (80%), 
while in the item of LDL-C, there was a predomi-
nance of persons with high levels (63.6%). In the 
evaluation of the item of hs-CRP (74.8%) there was 
also of the normal strata among the participants. 
Only 26.5% of the study’s participants presen-
ted raised levels of ferritin. This protein’s mean 
concentration was 187.6 SD (±179.9) ng/mL. No 
statistically significant association was identified 
between the glycidic profile and that of ferritin. On 
the other hand, approximately 20% of the sample 
simultaneously presented raised LDL-C and ferritin 
(p=0.040). Furthermore, approximately 40% of the 
subjects with raised hs-CRP also had a statistically 
significant rise in ferritin (p=0.021) (Table 1).
Table 1.  Distribution of the participants according 
to association between the glycidic/lipid 
profile and ferritin. São Luís, Brazil. 2013..
Parameter
Ferritin
p value
FBG Raised
FBG
Normal 96(73.8%) 34(26.2%)
0.401*
Prediabetes 15(71.4%) 6(28.6%)
Hb A1c
Normal 46(76.7%) 14(23.3%)
0.242*
Prediabetes 65(71.4%) 26(28.6%)
Insulin
Normal 109(74.7%) 37(25.3%)
0.116**
Raised 2(40%) 3(60%)
HOMA
Normal 86(74.8%) 29(25.2%)
0.264*
Insulin resistance 25(69.4%) 11(30.6%)
HDL-C
Normal 78(74.3%) 27(25.7%)
0.370*
Low 33(71.7%) 13(28.3%)
LDL-C
Normal 45(68.7%) 10(31.3%)
0.040*
Raised 66(81.8%) 30(18.2%)
Total Cholesterol 
Normal 58(75.3%) 19(24.7%)
0.306*
Raised 53(71.6%) 21(28.4%)
Triglycerides
Normal 91(66.7%) 30(33.3%)
0.176*
Raised 20(75.2%) 10(24.8%)
hs-CRP
Normal 88(77.9%) 25(22.1%)
0.021*
Raised 23(60.5%) 15(39.5%)
*: corrected Yates’ Chi-squared test. **: Fisher’s Exact test.
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The subjects classified with prediabetes (p=0.016) 
and with insulin resistance (p=0.026) had higher 
and statistically significant serum concentrations of 
ferritin in relation to those with normal parame-
ters. Similarly, the participants with raised LDL-C 
had nearly doubled levels of ferritin in relation to 
patients with raised levels of cholesterol (p<0.001) 
(Table 2). 
In sequence, it may be observed that the per-
sons with raised ferritin had double the probabilities 
of presenting raised hs-CRP (odds ratio = 2.29/ p= 
0.036). 
Table 2.  Distribution of the participants, according to the glycemic, lipid and ferritin parameters. São Luís, 
Brazil. 2013.
Parameter
Ferritin
Bartlett 
test
p value
Mean (ng/mL) Median (ng/mL)
Standard Deviation 
(±) (ng/mL)
FBG 
Normal 173.5 132.7 169.5
0.109 0.016*
Prediabetes 274.8 191.9 219.5
Hb A1c
Normal 189.3 134.9 187.8
0.568 0.922*
Prediabetes 186.4 142 175.6
Insulin
Normal 183 134.9 178.6
0.932 0.088*
Raised 322.3 266.1 184.3
HOMA
Normal 169.5 118.1 170.9
0.274 0.026*
Insulin resistance 245.3 153.1 197.8
HDL-C
Normal 202.2 138 193.7
0.014 0.304**
Low 154.2 134.3 139.8
LDL-C
Normal 121.3 103.7 103.5
<0.001 <0.001**
Raised 225.5 151.6 202.5
Total cholesterol
Normal 172.2 141 152.5
0.012 0.827**
Raised 203.5 126 204.5
Triglycerides
Normal 189.7 136.6 177.2
0.543 0.768*
Raised 178.9 136 193.5
hs-CRP
Normal 177.9 134.4 172
0.229 0.255*
Raised 216.4 149.5 201.4
*: Student t-test. **: Mann-Whitney test.
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The correlations established between the varia-
bles of the glycidic and lipid profiles and that of fe-
rritin, based on the Pearson coefficient, were weak. 
The variables of FBG (r=0.269/p< 0.001) and LDL-C 
(r=0.274/p< 0.001) presented a positive and sta-
tistically significant correlation with the variable of 
ferritin. In the case of the item of HDL-C (r=-0.242/
p=0.003), there was a negative and statistically sig-
nificant correlation. In the other variables, such as 
HbA1c (r=0.125/p=0.126), insulin (r=0.134/p=0.100), 
the HOMA level (r=0.160/p=0.050), total cholesterol 
(r=0.077/p=0.349), triglycerides (r=0.011/p=0.398) 
and hs-CRP (r= 0.007/p=0.930) there was no statis-
tically significant evidence in the correlations made 
with ferritin.
Discussion
This study identified an association between LDL-C 
and ferritin levels. Studies undertaken with Euro-
pean and Asian patients reached the same conclu-
sion in samples with both men and women [15-20]. 
However, it is important to emphasize that a con-
siderable number of the subjects had prediabetes. 
We cannot, therefore, totally disregard the influence 
of this issue on the association identified.
Statistically significant associations were identi-
fied in this study between the serum levels of ferritin 
and the prediabetes and IR. 
Indeed, one meta-analysis concluded that greater 
ingestion of heme iron and an increase of stocks of 
iron in the body are associated with a greater risk 
of DM2. However, the total iron in the diet, of non-
heme iron, or use of supplements of this product, 
are not correlated with the appearance of DM2 [21]. 
In addition to iron levels, alterations in the transfe-
rrin receptor are also determinants for increasing 
the chances of developing DM2 [16].
Data from a randomized double-blind study with 
persons with MetS, termed prediabetes by some 
researchers, presented divergent data. In that study, 
the reduction of status iron was induced through 
phlebotomy (the removal of approximately 300 mL 
of blood) on two occasions, separated by four wee-
ks, over a six-week period. At the end, there was a 
significant improvement in glycemic and lipid para-
meters in the intervention group [22].
The role of the metabolism of iron in the risk for 
DM is not totally clear, although some explanations 
have been put forward. The excessive depositing 
of iron in the liver can increase the production of 
local glucose or even favor a situation of nonalco-
holic steatosis (an independent risk factor for DM2). 
Another possible explanation is the oxidative stress 
in pancreatic cells triggered by the excess of the 
concentration of iron. The chronic inflammation 
could be responsible for IR and the development 
of new cases of MetS [23]. 
In relation to the chronic inflammation, it is im-
portant to highlight that in this study, the probabi-
lities of having raised hs-CRP were doubled in those 
with raised levels of ferritin. Raised levels of hs-CRP 
have been considered as one of the principal focu-
ses for studies on the risk for diabetes; in addition 
to this, they are mentioned as predictors for obesity, 
unstable angina, MetS and IR. However, in relation 
to diabetes, this association has not been not totally 
established and clarified, as there are divergent data 
[24-25]. 
As it is a protein, a marker of systemic inflam-
mation, in which a rise occurs in response to various 
types of injury, particularly in bacterial infections, 
this finding should be observed with caution. In-
dependently of this, it is recommended that levels 
of us-CRP should be monitored in the primary and 
secondary prevention of diabetes in the health ser-
vices, given that the role of chronic low intensity 
inflammation in the pathogenesis and progression 
of DM2 and arteriosclerosis is known. 
Broadly speaking, it is necessary to be cautious in 
generalizing from this study’s data, as there may be 
differences in the serum levels of ferritin according 
to the study sample’s ethnicity [23]. Furthermore, 
this study presents some limitations in its underta-
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king, namely: it is a study with a small sample size; 
and sleep quality, eating habits and kidney and liver 
functions were not evaluated simultaneously. All are 
possible triggers of interference in the metabolism of 
iron. As a result, it is suggested that further studies 
be undertaken on this issue with young nondiabetic 
persons, and over a longer period of monitoring.
In Brazil, the monitoring of levels of ferritin, iron 
or hs-CRP are not part of the guidelines of the Brazi-
lian Diabetes Society or of the official manuals used 
in the primary care services. 
Establishing correlations between markers for IR 
and ferritin levels may be important in the tracking 
of persons who are vulnerable in relation to diabe-
tes.
Conclusions
Among the participants with raised levels of ferritin, 
approximately 20% and 40%, respectively, conco-
mitantly had raised LDL-C and hs-CRP. Prediabetes 
and insulin resistance presented statistically signifi-
cant association with raised levels of ferritin. The 
participants with raised ferritin levels also presented 
double the chances of presenting raised hs-CRP.
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